User experimentation suggests that longer initial treatment periods (6+ months continuous) support better benefit retention during subsequent breaks, complete discontinuation breaks of 1-2 months show acceptable benefit maintenance for most users, and very extended breaks (3-6+ months) increase risk of regression toward pre-treatment baseline particularly for short initial treatment courses
Unlike its full-dose counterpart, LDN briefly blocks opioid receptors, triggering a rebound effect that boosts your body's endorphin production
Loose stools are common, especially early in treatment, and usually settle as your body adjusts
The Fertility Question: Weight loss achieved through Wegovy or Zepbound can sometimes restore ovulation, which can be a welcome side effect for women struggling with obesity-related infertility
Most weight loss evidence comes from studying each medication separately or from observational data in clinical practice
But your ability to measure accurate doses absolutely depends on this choice